Defining Patient-Reported Outcomes  by Doward, Lynda C. & McKenna, Stephen P.
 Volume 7 • Supplement 1 • 2004
V A L U E  I N  H E A L T H
 
© ISPOR 1098-3015/04/$15.00/S4 S4–S8
 
S4
 
Blackwell Science, LtdOxford, UK
 
VHEValue in Health1098-30152004 Blackwell Publishing
 
7Supplement 1S4S8
 
Original Article
 
Deﬁning Patient-Reported OutcomesDoward and McKenna
 
Address correspondence to:
 
 Lynda Doward, Galen Research,
Enterprise House, Manchester Science Park, Lloyd Street
North, Manchester M15 6SE, UK. E-mail: ldoward@galen-
research.com
 
Defining Patient-Reported Outcomes
 
Lynda C. Doward, BSc, Stephen P. McKenna, PhD
 
Galen Research, Manchester, UK
 
ABSTRACT
 
This paper considers and deﬁnes the different types of
patient-reported outcomes that can be collected in clinical
studies. In particular, it argues that quality of life (QoL) is
a distinctly different type of outcome from Health-
Related Quality of Life (HRQL). QoL is seen as providing
an overall assessment of the effect of both illness and its
treatment on the patient. In contrast, HRQL assesses
issues that are of clinical or societal importance that may
or may not cause concern to the patient. Needs-based
QoL is deﬁned and it is argued that this approach (the
extent to which an individual is able to meet his or her
needs) provides a good working indicator of QoL.
Keywords: disability, health-related quality of life,
impairment, well-being.
 
Introduction
 
“We should set the highest value, not on living, but on liv-
ing well.”—Socrates [1]
 
Before it is possible to decide which instruments
to select to assess patient-reported outcomes
(PROs), it is essential to be clear about the con-
structs that need to be assessed. The purpose of this
paper is to deﬁne the PROs that can be measured
and to comment on their respective functions and
applicability in the context of clinical studies and
trials. It is common for authors to describe anything
they have measured as quality of life (QoL)—simply
because the information was collected from
patients. It should be noted that “patient-reported”
implies that the instrument is completed by the
patient. It should not be inferred from this term that
the information gained is necessarily of direct con-
cern to the patient.
 
Impairment, Disability, and Handicap
 
The constructs of impairment, disability, and hand-
icap have been clearly deﬁned in the International
Classiﬁcation of Impairments, Disabilities, and
Handicaps (ICIDH [2]) and are widely accepted.
Recently the term disability has been replaced by
activity without affecting the classiﬁcation to any
great extent. Handicap is now termed participation,
deﬁned as “the nature or extent of a person’s
involvement in life situations in the manner and to
the extent expected.” These changes have been
largely driven by problems with the acceptability of
the original terms and difﬁculties with the handicap
classiﬁcations [3]. However, as the original terms
are more useful for deﬁning outcome and are easily
accessible in the ICIDH manual, they are employed
below.
 
Impairment
 
Impairment is any loss or abnormality of psycho-
logical, physiological, or anatomical structure or
function and equates to symptoms. This outcome
relates to disturbances at the level of the organ and
examples include anxiety, depression, pain, and
problems with sleep.
Impairment is seen as representing some devia-
tion from the norm in the individual’s biomedical
status. The value of the construct lies in determining
the impact of the disease from a clinical viewpoint,
informing on the symptoms associated with a dis-
ease and on the adverse effects of interventions. As
such, the value of the construct in the context of a
clinical trial is clear and rarely questioned. Its rele-
vance to QoL is a different matter. Impairments that
patients are unaware of cannot inﬂuence QoL
directly. Even where the patient is aware of impair-
ment it may not concern them in the least.
 
Disability (Activity)
 
A disability is any restriction or lack of ability to
perform an activity in the manner or within the
range considered normal for a human. Examples
 Deﬁning Patient-Reported Outcomes
 
S5
 
include problems with dressing, walking, or per-
sonal care. Again, disability is seen as being a devi-
ation from the norm and there is no need for an
individual to be aware that they have a restriction.
Such a deﬁnition introduces cultural bias to the
classiﬁcation. For example, behavior considered
uncooperative in one culture may be seen as
acceptable in others. Disability equates to function-
ing or functional status, constructs that play a
major part in the assessment of Health-Related
Quality of Life.
The assessment of disability is valuable for the
planning of interventions and rehabilitation serv-
ices. It is also essential to measure disability where
the primary objective of a trial is to detect improve-
ments in functioning.
 
Handicap (Participation)
 
Handicap is the disadvantage arising from impair-
ment or disability that prevents the fulﬁllment of the
normal or expected role for that person. What is
normal should take account of the individual’s age,
gender, and social and cultural background. Six
main types of handicap are listed in the ICIDH:
orientation, physical independence, mobility, occu-
pation, social integration, and economic self-
sufﬁciency. Some are relatively clearly deﬁned. For
example, mobility handicap is deﬁned as an individ-
ual’s ability to move about effectively in his sur-
roundings. Categorization is dependent on the
extent to which the individual is restricted; to bed,
chair, room, dwelling, neighborhood, or levels of
immobility. Similarly, physical dependence handi-
cap is related to the frequency with which the indi-
vidual can be left alone.
Handicap represents deviation of the individual’s
behavior or status from that of the group to which
he or she belongs. As this deviation may be from
choice, handicap is judged from the perspective of
society; it is not a personal but a social problem.
Thus, handicap represents the impact of disease on
society as a whole, rather than on the individual
patient. Therefore, it cannot be considered to be
directly relevant to QoL. The construct is of value in
determining the need for provision of social services
such as education, housing, or social security.
 
Well-Being
 
The concept of well-being has a checkered history
and now appears to be used as a catch-all term, cov-
ering anything that an author wishes to measure.
Subjective well-being was ﬁrst formally assessed as
part of the social indicators movement in the 1960s
and 1970s. It has been deﬁned as “a decent stand-
ard of living” [4], as “the extent to which pleasure
and satisfaction characterize human existence” [5],
and as happiness [6]. Well-being is generally related
to mood and is measured at the impairment level.
Dupuy [7] conceived of well-being as reﬂecting an
individual’s inner personal state. His widely used
scale, the Psychological General Well-Being
Schedule, includes items inquiring about anxiety,
depression, general health, positive well-being, self-
control, and vitality and, consequently, operates at
the level of impairment.
Scandinavian researchers have considered
aspects of well-being to constitute QoL. For exam-
ple, Naess [8,9] deﬁned QoL as an individual’s inner
affective state. Nordenfelt [10] also identiﬁed QoL
with subjective happiness-with-life. These various
deﬁnitions of well-being all suggest that the con-
struct falls predominantly at the level of mood
(impairment). As such, it does not represent QoL
(although it is likely to inﬂuence the construct) and
its measurement may add little to the assessment of
relevant symptoms in a clinical trial.
 
Health-Related Quality of Life (HRQL)
 
HRQL, as deﬁned by different authors, equates pri-
marily to impairment and disability. It has its ori-
gins in the functionalist approach of Durkheim in
the late-19th century [11], who analyzed social and
cultural phenomena in terms of the functions they
perform in a sociocultural system. Early attempts to
develop outcome instruments were strongly rooted
in this tradition; in 1949, Karnofsky and Burchenal
[12] outlined criteria for the evaluation of new ther-
apeutic agents that included performance states,
mood, and well-being, together with traditional
indicators such as survival. Function-based meas-
ures appeared particularly attractive to a medical
world of the 1950s and 1960s that was reluctant to
embrace subjective elements in outcome assessment.
The concept was developed further by Parsons [13]
who deﬁned health as “the state of optimum capac-
ity for the effective performance of valued tasks.” In
this system, illness becomes a problem when it
affects role performance and health is the most val-
ued state of existence [14,15]. Thus, functionalist
deﬁnitions of health focus on the main social roles
considered “normal” for people in western socie-
ties. Following from this, HRQL has been deﬁned
as “the capacity to perform the usual daily activities
for a person’s age and major social role” [16]. Thus,
deviation from normality results in a reduced
HRQL.
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There is general agreement that HRQL is multi-
dimensional, although there is no formal consensus
on the domains that should be included [17–19].
Torrance [20] argues that it is inappropriate to
include social functioning as a dimension of HRQL
as it is, “beyond the skin.” Some researchers suggest
that it is only necessary to assess those domains that
are relevant to the study [21]. Taken to its extreme,
studies have been criticized for using a single vari-
able such as employment, happiness, or sexual func-
tioning, as ad hoc indicators of HRQL. Spilker has
pointed out the pitfalls of such an approach [22].
Recently, clear distinctions have been made
between the HRQL dimensions and QoL [23–25]
with QoL seen as going beyond the impairment–dis-
ability–handicap continuum assessed by HRQL
instruments [23]. Bradley points out the value of
assessing QoL in addition to HRQL [26]. She
argues that “clinicians may be misled into thinking
that ﬁndings based on a health-status instrument
indicate that treatments do not damage QoL when
all the data reveal is that treatments do not damage
perceived health.”
In summary, HRQL focuses on those aspects of
life that are considered to be the province of health
professionals. Its emphasis is on the measurement of
symptoms and functions. Consequently, the main
value of HRQL measurement is in the assessment of
health status; levels of impairment, disabilities, and,
to a lesser extent, handicap [1]. Such information is
valuable to clinical assessment of outcome. How-
ever, the focus on fulﬁllment of “normal” roles
creates problems in that groups, such as the unem-
ployed or disabled, are automatically devalued. The
emphasis on physical functioning found in HRQL
instruments determines that disabled people cannot
have a good “QoL”; a fact that is not borne out by
experience.
 
Quality of Life
 
It is clear that QoL goes beyond the continuum sug-
gested by the World Health Organization [23] but it
should not be conceived of as the next step in a
linear progression. The consequences of disease and
its treatment represent one group of inﬂuences on
QoL. However, there are many more including per-
sonality, economic status, environment, social rela-
tionships, and culture. The extent to which an
impairment or disability inﬂuences QoL is depend-
ent on other inﬂuences. For example, the impact of
a skin disease will depend on whether the lesions are
hidden by clothes, the climate, and quality of per-
sonal relationships, stage of life, and many other
factors. Patients may give up functions that become
problematic, such as swimming or sun-bathing and
take up other leisure activities in order to maintain
their QoL. Function-based measures are unable to
cope with such adaptation making it difﬁcult for
severely ill or disabled patients to show improve-
ment, even following effective interventions.
Figure 1 shows a simpliﬁed representation of
how disease relates to some of the other inﬂuences
on an individual’s QoL. To obtain a complete pic-
ture of the impact of disease and of the effectiveness
of treatment, it is essential to measure QoL. Focus-
ing on impairments and disability alone is insufﬁ-
cient. Handicap is omitted from this model as it is
the disadvantage arising from impairment and dis-
ability from the perspective of society rather than
the individual.
 
Needs-Based QoL
 
In the ﬁeld of health research, the most widely
implemented approach to the measurement of QoL,
as opposed to HRQL, is needs-based. It is argued
that individuals are driven or motivated by their
needs and that the fulﬁllment of these provides sat-
isfaction. Consequently, life derives its quality from
the ability and capacity of the individual to satisfy
certain human needs. QoL is good when most needs
are fulﬁlled and poor when few needs are satisﬁed.
 
Figure 1
 
Inﬂuences on QoL.
QoL 
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Social 
HRQL 
Treatment 
Impairments 
(symptoms) 
Disability 
(functioning) 
Environment 
Personality 
Culture / 
economy
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For example, the function of walking may lead to
the satisfaction of several needs including gaining
exercise and pleasure, socialization needs, purchas-
ing essential food, communication needs (posting
letters), or obtaining medical advice.
Advocates of the needs-based approach view
QoL as a construct distinct from function and
health status. Gill and Feinstein [27] argue that
QoL, rather than being a description of a patient’s
health status, is a reﬂection of the way in which
patients perceive and react to their health status and
to other nonmedical aspects of their lives. The QoL
issue is whether the individual is able to fulﬁll his or
her needs. Functioning is only important insofar as
it permits need fulﬁllment. For example, employ-
ment provides income but it also provides fulﬁll-
ment of a number of basic human needs (see Fig. 2).
 
Advantages of  the Needs-Based Approach to 
QoL Assessment
 
The needs-based approach has a number of advan-
tages for measurement. Rather than asking directly
about a function, it is possible to inquire about the
needs that could be satisﬁed by that function. For
example, questions about sexual performance are
frequently left unanswered in questionnaires. The
needs approach allows questions to be asked about
needs related to sexual functioning but which can
also be satisﬁed in other ways such as love, inti-
macy, touch, and sharing with another person. The
needs-based approach avoids irrelevant questions
and considerably reduces the number of missing
responses.
As there will be an overlap between conditions in
the needs that are relevant it is possible to develop
valid methods of making comparisons between the
impact of different conditions using cocalibration
techniques and item banking. While it is feasible to
develop a generic needs-based measure, this would
suffer from similar problems as generic HRQL
instruments with important needs omitted and the
coverage of irrelevant needs for the speciﬁc
condition.
The needs approach also copes well with patient
adaptation. A chronically ill person can maintain a
reasonable level of QoL by remaining independent
through the use of aids and/or assistance. Patients
who have functional limitations can still be shown
to have a good QoL, as the concern here is the
degree to which they can meet their needs, irrespec-
tive of how this is achieved.
A further advantage is that needs are, on the
whole, culture-free, although the degree to which
higher needs become important may vary between
extremes of culture. For example, the needs for love
and affection, communication, and safety would be
expected to be common around the world. Conse-
quently, instruments based on this approach are
more amenable to adaptation for use in other coun-
tries and for use with cultural minority groups
within a society.
Measures developed using the needs approach
are disease-speciﬁc, although a better term might be
disease-relevant. This allows them to focus on the
speciﬁc needs interfered with by the disease and
hence makes them highly relevant and acceptable to
the patient group. Such instruments assess a single
construct; that is, the extent to which needs are ful-
ﬁlled. Consequently, they consist of a single unidi-
mensional scale, providing an index of QoL.
Needs-based measures only include items that
are generated directly from patients, thus fulﬁlling a
basic requirement for QoL instruments. They do
not contain predetermined components; rather, the
content is derived from in-depth qualitative inter-
views conducted with relevant patients. As instru-
ments reﬂect the concerns of the patient group, their
acceptability to respondents is maximized and miss-
ing data reduced to a minimum [28]. Response rates
are also consistently high. For example, when test-
ing the reproducibility of the QoL-AGHDA [29], a
needs-based measure for adult growth hormone
deﬁciency, by means of a test–retest postal survey,
the overall response rate was 98% with virtually no
missing responses.
 
Conclusions
 
These various advantages of the needs-based
approach combined with high psychometric stand-
ards explain why this family of QoL measures has
proved successful when applied in clinical studies
and trials. Perhaps their main value is that they pro-
vide information on the impact of disease and its
treatment that is known to be of importance to the
 
Figure 2
 
Needs fulﬁlled by paid employment.
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patient, rather than that which is of interest to
professionals.
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